Why the study?
Primary aldosteronism has a complex diagnostic process and an incompletely understood pathogenesis.
Do arachidonic acid metabolites improve subtype classification and elucidate the pathogenesis of primary aldosteronism?
Population
37 patients with bilateral PA, 38 with unilateral PA, and 20 with EH
Comparison
Bilateral PA vs unilateral PA vs essential hypertension
Design
Controlled cross-sectional study
Authors
Loading...
May aid PA subtyping; leaves open clinical utility pending prospective validation.
Do arachidonic acid metabolites improve subtype classification and elucidate the pathogenesis of primary aldosteronism?
Arachidonic acid metabolites improve the subtyping of primary aldosteronism and may play a pathogenic role by stimulating adrenal cortical cells via TRPC3.
You et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: